Spots Global Cancer Trial Database for stage iv nasopharyngeal cancer
Every month we try and update this database with for stage iv nasopharyngeal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC | NCT00609219 | Head and Neck C... | autologous EBV ... | - | Baylor College of Medicine | |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | NCT00002901 | Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | docetaxel | 18 Years - | City of Hope Medical Center | |
| Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer | NCT00003206 | Head and Neck C... | carboplatin paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | NCT00004097 | Head and Neck C... | fluorouracil gemcitabine hyd... paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | NCT00002901 | Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | docetaxel | 18 Years - | City of Hope Medical Center | |
| Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function | NCT00002901 | Breast Cancer Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | docetaxel | 18 Years - | City of Hope Medical Center | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer | NCT00003206 | Head and Neck C... | carboplatin paclitaxel | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Docetaxel in Treating Patients With Solid Tumors | NCT00003565 | Bladder Cancer Breast Cancer Head and Neck C... Lung Cancer Unspecified Adu... | docetaxel | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer | NCT00003251 | Drug/Agent Toxi... Head and Neck C... Radiation Toxic... | amifostine trih... cisplatin paclitaxel radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx | NCT00002999 | Head and Neck C... | cisplatin fluorouracil radiation thera... | - | SWOG Cancer Research Network | |
| Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer | NCT00003327 | Head and Neck C... | paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer | NCT00008398 | Head and Neck C... Oral Complicati... Radiation Toxic... | sargramostim quality-of-life... radiation thera... | - | Radiation Therapy Oncology Group | |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
| Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer | NCT00305734 | Recurrent Nasop... Stage IV Nasoph... | bortezomib gemcitabine hyd... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck | NCT00003182 | Head and Neck C... | cisplatin gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck | NCT00006361 | Carcinoma of Un... Head and Neck C... Non-melanomatou... | semaxanib | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx | NCT00025298 | Drug/Agent Toxi... Head and Neck C... Oral Complicati... Radiation Toxic... | amifostine trih... carboplatin cisplatin paclitaxel radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors | NCT00499291 | Cancer | paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer | NCT00022373 | Head and Neck C... Oral Complicati... Radiation Toxic... | iseganan HCl or... management of t... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
